, Tracking Stock Market Picks
Enter Symbol:
Xoma Ltd. (XOMA) [hlAlert]

down 97.36 %

Xoma Ltd. (XOMA) rated Buy

Posted on: Friday,  Oct 12, 2007  9:25 AM ET by BWS Financial

BWS Financial rated Buy Xoma Ltd. (NASDAQ: XOMA) on 10/12/2007. Previously BWS Financial rated Buy Xoma Ltd. (NASDAQ: XOMA) on 08/01/2007.,
when the stock price was $31.50. Since then, Xoma Ltd. has lost 97.37% as of 11/27/2015's recent price of $0.83.
If you would have followed the previous BWS Financial's recommendation on XOMA, you would have lost 97.36% of your investment in 3040 days.

XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies, with a therapeutic focus that includes cancer and immune diseases. XOMA has royalty interests in RAPTIVA, a monoclonal antibody product marketed worldwide to treat moderate-to-severe plaque psoriasis, and LUCENTIS, a monoclonal antibody product marketed worldwide to treat neovascular age-related macular degeneration. The company has built a premier antibody discovery and development platform that includes access to seven of the leading commercially available antibody phage display libraries and XOMA's proprietary Human Engineering and bacterial cell expression technologies. More than forty five companies have signed BCE licenses. XOMA's development collaborators include Lexicon Genetics, Inc., Novartis, and Schering-Plough Corporation. With a fully integrated product development infrastructure, XOMA's product development capabilities extend from preclinical sciences to product launch.

· BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology, healthcare and technology industries. · BWS Financial focuses on companies that hold much potential in their industries, either through their product pipeline or technological innovations. · BWS Financial’s strategy is not to only specialize in a particular group of stocks, but to also provide investors with insight into other ideas where there is considerable misvaluation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/12/2007 9:25 AM Buy
63.75 82.50
as of 8/27/2015
1 Week up  7.79 %
1 Month down  -80.56 %
3 Months down  -75.80 %
1 YTD down  -87.66 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/12/2007 9:25 AM Buy
63.75 82.50
8/1/2007 9:25 AM Buy
31.50 49.20

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy